Oral and Intravenous Iron in Patients Postoperative Cardiovascular Surgery Under Extracorporeal Circulation

PHASE4CompletedINTERVENTIONAL
Enrollment

159

Participants

Timeline

Start Date

May 31, 2007

Primary Completion Date

May 31, 2009

Study Completion Date

May 31, 2009

Conditions
Anaemia
Interventions
DRUG

IV trivalent saccharose hydroxide ferrous

"Preoperative Period 5-10 days 200 mg Iron iv (Venofer® )in 200cc physiologic solution /24-48h x 3 dosis +1 oral placebo /24h Postoperative Period 1-3weeks 200 mg Iron iv (Venofer® )in 200cc physiologic solution/24-48h x 3 dosis + 1 oral placebo /24h One month Follow-up~1 month 1 oral placebo /24h"

DRUG

Oral ferrous fumarate

"200cc physiologic solution iv placebo /24-48h x 3 dosis + 1 oral iron tablet/24h (Ferogradumet®)~Postoperative Period:~200cc physiologic solution iv placebo /24-48h x 3 dosis + 1 oral iron tablet/24h (Ferogradumet®) One month Follow-up: 1 oral iron tablet/24h Ferogradumet"

DRUG

Oral and intravenous Placebo

Preoperative Period:1oral placebo/24h Postoperative Period:200cc physiologic solution iv placebo /24-48h x 3 dosis + 1oral placebo/24h One month Follow-up:1 oral placebo/24h

Trial Locations (1)

38320

Hospital Universitario de Canarias, Santa Cruz de Tenerife

All Listed Sponsors
lead

Fundación Canaria Rafael Clavijo para la Investigación Biomédica

OTHER

NCT01078818 - Oral and Intravenous Iron in Patients Postoperative Cardiovascular Surgery Under Extracorporeal Circulation | Biotech Hunter | Biotech Hunter